ROFRX
Price
$13.28
Change
-$0.52 (-3.77%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

ROFRX vs VSIAX

Header iconROFRX vs VSIAX Comparison
Open Charts ROFRX vs VSIAXBanner chart's image
Royce Small-Cap Opportunity R
Price$13.28
Change-$0.52 (-3.77%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
ROFRX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ROFRX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROFRX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. ROFRX (1.22B). VSIAX pays higher dividends than ROFRX: VSIAX (2.01) vs ROFRX (0.00). ROFRX was incepted earlier than VSIAX: ROFRX (18 years) vs VSIAX (13 years). ROFRX is a more actively managed with annual turnover of: 35.00 vs. VSIAX (16.00). ROFRX has a lower initial minimum investment than VSIAX: ROFRX (1000) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. ROFRX (7.73). VSIAX return over 5 years is better than : 52.83 vs. ROFRX (24.21).
ROFRXVSIAXROFRX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years13 years-
Gain YTD4.70415.03131%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.22B63B2%
Annual Yield % from dividends0.002.01-
Returns for 1 year7.7316.2348%
Returns for 3 years-2.2720.67-11%
Returns for 5 years24.2152.8346%
Returns for 10 years11.74105.6511%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics